{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:08:05Z","timestamp":1792804085254,"version":"4.5.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:sec id=\"ab-coi240055-4\"><jats:title>Importance<\/jats:title><jats:p>The Fracture Risk Assessment Tool (FRAX) is a fracture risk prediction tool for 10-year probability of major osteoporotic fracture (MOF) and hip fracture in the general population. Whether FRAX is useful in individuals with cancer is uncertain.<\/jats:p><\/jats:sec><jats:sec id=\"ab-coi240055-5\"><jats:title>Objective<\/jats:title><jats:p>To determine the performance of FRAX for predicting incident fractures in individuals with cancer.<\/jats:p><\/jats:sec><jats:sec id=\"ab-coi240055-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This retrospective population-based cohort study included residents of Manitoba, Canada, with and without cancer diagnoses from 1987 to 2014. Diagnoses were identified through the Manitoba Cancer Registry. Incident fractures to March 31, 2021, were identified in population-based health care data. Data analysis occurred between January and March 2023.<\/jats:p><\/jats:sec><jats:sec id=\"ab-coi240055-7\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>FRAX scores were computed for those with bone mineral density (BMD) results that were recorded in the Manitoba BMD Registry.<\/jats:p><\/jats:sec><jats:sec id=\"ab-coi240055-8\"><jats:title>Results<\/jats:title><jats:p>This study included 9877 individuals with cancer (mean [SD] age, 67.1 [11.2] years; 8693 [88.0%] female) and 45\u202f877 individuals in the noncancer cohort (mean [SD] age, 66.2 [10.2] years; 41\u202f656 [90.8%] female). Compared to individuals without cancer, those with cancer had higher rates of incident MOF (14.5 vs 12.9 per 1000 person-years; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) and hip fracture (4.2 vs 3.5 per 1000 person-years; <jats:italic>P<\/jats:italic>\u2009=\u2009.002). In the cancer cohort, FRAX with BMD results were associated with incident MOF (HR per SD increase, 1.84 [95% CI, 1.74-1.95]) and hip fracture (HR per SD increase, 3.61 [95% CI, 3.13-4.15]). In the cancer cohort, calibration slopes for FRAX with BMD were 1.03 for MOFs and 0.97 for hip fractures.<\/jats:p><\/jats:sec><jats:sec id=\"ab-coi240055-9\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this retrospective cohort study, FRAX with BMD showed good stratification and calibration for predicting incident fractures in patients with cancer. These results suggest that FRAX with BMD can be a reliable tool for predicting incident fractures in individuals with cancer.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoncol.2024.4318","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T15:32:27Z","timestamp":1727969547000},"page":"1554","source":"Crossref","is-referenced-by-count":14,"title":["Fracture Risk Prediction Using the Fracture Risk Assessment Tool in Individuals With Cancer"],"prefix":"10.1001","volume":"10","author":[{"given":"Carrie","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Leslie","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Al-Azazi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Lix","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Czaykowski","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"CancerCare Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene V.","family":"McCloskey","sequence":"additional","affiliation":[{"name":"Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Johansson","sequence":"additional","affiliation":[{"name":"Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, United Kingdom"},{"name":"Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Harvey","sequence":"additional","affiliation":[{"name":"MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom"},{"name":"NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kanis","sequence":"additional","affiliation":[{"name":"Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harminder","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"CancerCare Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"coi240055r1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00198-022-06631-4","article-title":"Fracture risk and assessment in adults with cancer.","volume":"34","author":"Ye","year":"2023","journal-title":"Osteoporos Int"},{"issue":"20 Pt 2","key":"coi240055r2","doi-asserted-by":"publisher","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity.","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"17","key":"coi240055r3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010532","article-title":"Osteoporosis and fracture after gastrectomy for stomach cancer: a nationwide claims study.","volume":"97","author":"Seo","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"coi240055r4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/13697137.2015.1020484","article-title":"Long-term health consequences of premature or early menopause and considerations for management.","volume":"18","author":"Faubion","year":"2015","journal-title":"Climacteric"},{"issue":"1073","key":"coi240055r5","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20160885","article-title":"Pelvic insufficiency fracture (PIF) incidence in patients treated with intensity-modulated radiation therapy (IMRT) for gynaecological or anal cancer: single-institution experience and review of the literature.","volume":"90","author":"Bazire","year":"2017","journal-title":"Br J Radiol"},{"issue":"10","key":"coi240055r6","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/jbmr.3523","article-title":"Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions.","volume":"33","author":"Balasubramanian","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"4","key":"coi240055r7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00198-023-06690-1","article-title":"Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event.","volume":"34","author":"Ye","year":"2023","journal-title":"Osteoporos Int"},{"issue":"4","key":"coi240055r8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00198-011-1724-9","article-title":"Prevalence of osteoporosis among cancer patients in Germany: prospective data from an oncological rehabilitation clinic.","volume":"23","author":"Reuss-Borst","year":"2012","journal-title":"Osteoporos Int"},{"issue":"1","key":"coi240055r9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00520-020-05619-2","article-title":"Falls in older adults with cancer: an updated systematic review of prevalence, injurious falls, and impact on cancer treatment.","volume":"29","author":"Sattar","year":"2021","journal-title":"Support Care Cancer"},{"issue":"12","key":"coi240055r10","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1007\/s00198-022-06542-4","article-title":"Fractures and long-term mortality in cancer patients: a population-based cohort study.","volume":"33","author":"Ye","year":"2022","journal-title":"Osteoporos Int"},{"issue":"2","key":"coi240055r11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00198-020-05596-6","article-title":"Cancer patients with fractures are rarely assessed or treated for osteoporosis: a population-based study.","volume":"32","author":"Leslie","year":"2021","journal-title":"Osteoporos Int"},{"issue":"6","key":"coi240055r12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.5144\/0256-4947.1994.527","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis assessment of fracture risk and its application to screening for postmenopausal osteoporosis.","volume":"14","author":"Ghannam","year":"1994","journal-title":"Ann Saudi Med"},{"key":"coi240055r13","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.6004\/jnccn.2013.0215","article-title":"NCCN Task Force report: bone health in cancer care.","volume":"11","author":"Gralow","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"coi240055r14","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1007\/s00198-013-2530-3","article-title":"Cancer-associated bone disease.","volume":"24","author":"Rizzoli","year":"2013","journal-title":"Osteoporos Int"},{"issue":"31","key":"coi240055r15","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1200\/JCO.19.01696","article-title":"Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO Clinical Practice Guideline.","volume":"37","author":"Shapiro","year":"2019","journal-title":"J Clin Oncol"},{"key":"coi240055r16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ctrv.2016.10.004","article-title":"Bone health in the elderly cancer patient: a SIOG position paper.","volume":"51","author":"Body","year":"2016","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"coi240055r17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11657-018-0510-0","article-title":"A brief history of FRAX.","volume":"13","author":"Kanis","year":"2018","journal-title":"Arch Osteoporos"},{"issue":"6","key":"coi240055r19","first-page":"JS10","article-title":"Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system.","volume":"37","author":"Roos","year":"1999","journal-title":"Med Care"},{"issue":"1","key":"coi240055r23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1385\/JCD:8:1:025","article-title":"Construction and validation of a population-based bone densitometry database.","volume":"8","author":"Leslie","year":"2005","journal-title":"J Clin Densitom"},{"issue":"11","key":"coi240055r24","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1345\/aph.18117","article-title":"Validation of an electronic, population-based prescription database.","volume":"32","author":"Kozyrskyj","year":"1998","journal-title":"Ann Pharmacother"},{"key":"coi240055r27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/1471-2458-12-301","article-title":"Osteoporosis-related fracture case definitions for population-based administrative data.","volume":"12","author":"Lix","year":"2012","journal-title":"BMC Public Health"},{"key":"coi240055r28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11657-013-0143-2","article-title":"Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study.","volume":"8","author":"O\u2019Donnell","year":"2013","journal-title":"Arch Osteoporos"},{"issue":"1","key":"coi240055r29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11657-021-00980-z","article-title":"Assessment of site-specific X-ray procedure codes for fracture ascertainment: a registry-based cohort study.","volume":"16","author":"Leslie","year":"2021","journal-title":"Arch Osteoporos"},{"issue":"3","key":"coi240055r30","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00198-010-1464-2","article-title":"Construction of a FRAX model for the assessment of fracture probability in Canada and implications for treatment.","volume":"22","author":"Leslie","year":"2011","journal-title":"Osteoporos Int"},{"issue":"5","key":"coi240055r31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/jbmr.4793","article-title":"Performance of FRAX in men with prostate cancer: a registry-based cohort study.","volume":"38","author":"Ye","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"8","key":"coi240055r32","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/jbmr.3726","article-title":"Performance of FRAX in women with breast cancer initiating aromatase inhibitor therapy: a registry-based cohort study.","volume":"34","author":"Leslie","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"6","key":"coi240055r33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.berh.2009.09.002","article-title":"How to decide who to treat.","volume":"23","author":"Kanis","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"coi240055r34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11657-020-00748-x","article-title":"A comparison of the Cox model to the Fine-Gray model for survival analyses of re-fracture rates.","volume":"15","author":"Nolan","year":"2020","journal-title":"Arch Osteoporos"},{"issue":"2","key":"coi240055r35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00198-012-2051-5","article-title":"Competing mortality and fracture risk assessment.","volume":"24","author":"Leslie","year":"2013","journal-title":"Osteoporos Int"},{"issue":"3","key":"coi240055r36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s40618-023-02219-9","article-title":"An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis.","volume":"47","author":"Schini","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"coi240055r37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jamaoncol.2022.5153","article-title":"Fracture risk among older cancer survivors compared with older adults without a history of cancer.","volume":"9","author":"Rees-Punia","year":"2023","journal-title":"JAMA Oncol"},{"key":"coi240055r38","first-page":"275","article-title":"Radiological validation of fracture definitions from administrative data: the Manitoba bone mineral density database.","volume":"33","author":"Epp","year":"2018","journal-title":"J Bone Miner Res"},{"key":"coi240055r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2022.100459","article-title":"Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: an exploratory analysis.","volume":"37","author":"Pantano","year":"2022","journal-title":"J Bone Oncol"},{"issue":"3","key":"coi240055r40","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/ijc.33592","article-title":"Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: case series and large-scale pharmacovigilance analysis.","volume":"149","author":"Filippini","year":"2021","journal-title":"Int J Cancer"},{"key":"coi240055r18","unstructured":"Manitoba Bureau of Statistics. Province of Manitoba. Manitoba Bureau of Statistics. Accessed November 7, 2022. https:\/\/www.gov.mb.ca\/mbs\/"},{"key":"coi240055r20","unstructured":"North American Association of Central Cancer Registries. NAACCR certified registries. Published November 1, 2016. Accessed November 7, 2022. https:\/\/www.naaccr.org\/certified-registries\/"},{"key":"coi240055r21","unstructured":"Canadian Cancer Registry. Canadian Research Data Centre Network. Published September 16, 2021. Accessed November 7, 2022. https:\/\/crdcn.ca\/data\/canadian-cancer-registry\/"},{"key":"coi240055r22","unstructured":"Cancer in North America: 1999-2003. Incidence North American Association of Central Cancer Registeries Inc. https:\/\/www.naaccr.org\/cina-data-products-overview\/"},{"key":"coi240055r25","unstructured":"Manitoba Vital Statistics Branch. Province of Manitoba. Accessed March 21, 2023. https:\/\/vitalstats.gov.mb.ca\/"},{"key":"coi240055r26","unstructured":"Concept: Regional Health Authority (RHA) Districts and Zones in Manitoba. Accessed November 4, 2022. http:\/\/mchp-appserv.cpe.umanitoba.ca\/viewConcept.php?printer=Y&conceptID=1219"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2824314\/jamaoncology_ye_2024_oi_240055_1732041437.28699.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:01:07Z","timestamp":1732204867000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2824314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2024.4318","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}